Heart surgery cured man's cancer, gave him bee allergy
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- The man, a farmer in his 60s in Australia, had melanoma that had spread to his lymph nodes, liver and left thigh bone go into complete remission roughly two months after aortic stenosis surgery was complicated by a bacterial infection.
- Dabrafenib and trametinib, the targeted cancer drugs the man took daily, failed to shrink his tumors and caused severe side effects including liver damage that forced him to stop treatment after two months.
- Po Liu at Adelaide University and Michael Brown at Royal Adelaide Hospital wrote the BMJ Case Report, proposing that tissue injury plus infection released pro-inflammatory cytokines that activated T-cells capable of destroying the cancer.
- Rohit Sharma at the Marshfield Clinic said the man's new anaphylaxis to honeybee stings—after dozens of prior stings with no severe reaction—serves as a 'marker of a permanently reset immune system.'
- Rebecca Auer at The Ottawa Hospital noted that surgery typically suppresses immunity and worsens cancer outcomes, making this regression an outlier that could reveal drug-targetable immune pathways if its genetic basis is understood.
- More than 70 prior case studies have linked surgery to melanoma regression, and a recent report described a tumor biopsy alone likely triggering remission in a woman's arm.
Why it matters: If researchers can identify why surgery plus infection flipped this patient's immune system into anti-tumor mode, it could expose drug-targetable pathways for triggering cancer remission in others—though Auer cautions the effect may depend on this man's specific genetics.
Ask SkimNews
